Acadia Pharmaceuticals Set to Join S&P SmallCap 600
Rhea-AI Summary
Acadia Pharmaceuticals (NASD: ACAD) will be added to the S&P SmallCap 600 prior to the opening of trading on Jan 3, 2025, replacing Independent Bank Group (NASD: IBTX).
The change follows an announced acquisition involving SouthState (NYSE: SSB) and is effective before the market open on the stated date. For details, see S&P Dow Jones Indices.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
Market Reality Check
Peers on Argus
Regional bank peers FHN, WBS, BSAC, EWBC and WF each gained between 0.8% and 2.14%, while SSB rose only 0.14%, suggesting relatively modest stock-specific movement despite broader peer strength.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 03 | Stewardship report, merger | Positive | -1.2% | Corporate stewardship report highlighting completed Independent Financial merger and expansion. |
| Feb 12 | Service awards | Positive | -1.1% | National banking awards recognizing client satisfaction and advisory capabilities. |
| Jan 22 | Earnings, capital return | Positive | -0.4% | Strong Q4 2025 results with higher EPS, dividend declaration and new buyback plan. |
| Jan 21 | Strategic hiring | Positive | +3.8% | Hiring 32 seasoned producers across growth markets to support 2026 performance. |
| Jan 05 | Earnings date set | Neutral | +1.4% | Announcement of timing and access details for upcoming Q4 2025 earnings release. |
Recent fundamentally positive announcements have often coincided with flat-to-negative one-day price reactions, while strategic growth hires drew a stronger positive response.
Over recent periods, SouthState (SSB) reported solid operating performance and integration progress after acquiring Independent Bank Group, a transaction referenced in this index-change notice. Earnings for Q4 2025 delivered diluted EPS of $2.46 and net income of $247.7M, alongside dividends and a new buyback. Strategic hiring of 32 producers across key markets preceded a 3.81% gain. Corporate stewardship and awards news, as well as earnings communications, often saw modest or negative next-day moves, indicating a tendency for limited upside reaction to positive updates.
Market Pulse Summary
This announcement details an index reshuffling in which Acadia Pharmaceuticals enters the S&P SmallCap 600 as Independent Bank Group exits following its acquisition by SouthState. For SouthState, this ties into a broader integration story after expanding its footprint via that deal. Recent history highlights strong Q4 2025 results, active capital return, and strategic hiring. Investors may watch future disclosures on integration progress, loan growth, and profitability metrics to assess longer-term impact.
Key Terms
s&p smallcap 600 financial
s&p midcap 400 financial
gics sector technical
AI-generated analysis. Not financial advice.
NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE: SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions.
Following is a summary of the change that will take place prior to the open of trading on the effective date:
Effective Date | Index Name | Action | Company Name | Ticker | GICS Sector |
Jan 3, 2025 | S&P SmallCap 600 | Addition | Acadia Pharmaceuticals | ACAD | Health Care |
Jan 3, 2025 | S&P SmallCap 600 | Deletion | Independent Bank Group | IBTX | Financials |
For more information about S&P Dow Jones Indices, please visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.
FOR MORE INFORMATION:
S&P Dow Jones Indices
index_services@spglobal.com
Media Inquiries
spdji.comms@spglobal.com
View original content:https://www.prnewswire.com/news-releases/acadia-pharmaceuticals-set-to-join-sp-smallcap-600-302340435.html
SOURCE S&P Dow Jones Indices